Skip to main content
. 2015 Aug 16;31(1):24–30. doi: 10.5606/ArchRheumatol.2016.5562

Table 1. Description of 163 patients with ankylosing spondylitis in the study group.

  n %   Median Range
Age (year)     37.74±9.88 37 18-65
Age at symptom onset (year)     23.39±7.09 23 8-50
Age at diagnosis (year)     31.28±9.67 30 10-64
Diagnostic delay (year)     7.88±7.17 6 0-32
Disease duration (year)     14.49±8.47 14 1-44
Modified Schober (cm)     3.46±2.02 4 0-10
BASMI (0-10)     3.95±1.88 3,6 0.6-8.6
BASFI (0-10)     4.07±2.74 3,9 0-10
BASDAI (0-10)     4.54±2.30 4,60 0,2-10
ASQoL (0-18)     8.02±5.28 8 0-18
Chest expansion (cm)     4.24±1.94 4 0-14
Cervical rotation (degree)     62.14±21.07 67,5 0-95
Fatigue (VAS 0-10)     5.23±2.82 5 0-10
Tragus to wall (cm)     17.91±6.40 16 9-51
Educational level          
    Primary school & illiterate 34 20.8      
    Secondary school 2 1.2      
    High school 64 39.3      
    University 63 38.7      
Juvenile-onset ankylosing spondylitis (≤16 years) 26 16      
Family history of ankylosing spondylitis 50 30.7      
Peripheral arthritis 83 50.9      
Enthesitis 109 66.9      
Male sex 129 79.1      
Inflammatory bowel disease 11 6.7      
Uveitis 23 14.1      
Intermalleolar distance (cm)     95.42±24.15  97 0-170
Finger to floor distance (cm)     18.11±14.52 18 0-52
Sacroiliitis grading          
    II 53 32.5      
    III 76 46.6      
    IV 34 20.9      
Morning stiffness (VAS 0-10)     4.44±3.10 3 0-10
History of nephrolithiasis 19 11.7      
History of infection prior to disease onset# 15 9.2      
Positive HLA-B27 122 74.8      
B27 (05) 59 36.2      
B27 (02) 52 31.9      
B27 (04) 7 4.3      
B27 (07) 4 2.5      
SD: Standard deviation; BASMI: Bath ankylosing spondylitis metrology index; BASFI: Bath ankylosing spondylitis functional index; BASDAI: Bath ankylosing spondylitis disease activity index; ASQoL: Ankylosing spondylitis quality of life; VAS: Visual analog scale; HLA-B27: Human leukocyte antigen B27; # Value was reported in 158 cases (five missing cases).